Sherlock Biosciences aims to disrupt diagnostics by providing accurate, actionable health information wherever and whenever it is needed. It is mandatory to procure user consent prior to running these cookies on your website. Sherlock uses your contact information to update you about Sherlock’s products and services. Sitemap Dr. Abudayyeh earned his Ph.D. at the Broad Institute of Harvard and MIT. The Structural Molecular Biology Program at SSRL is supported by the DOE Office of Science and by the National Institutes of Health, National Institute of General Medical Sciences. Deadline: 14th October 2020 (For Graduates), 1st Nov 2020 (For Bachelors) Do You know you have 21 Days Left to Apply for … If you consent to us storing your personal data for this purpose, please tick the checkbox below. Davis received his B.A. After that, she obtained her medical degree summa cum laude from Harvard Medical School as a Soros Fellow. Sherlock’s team has deep experience in the diagnostic industry and with the most important innovations that are revolutionizing the field. Mission Statement Recruit and develop a distinguished group of postdoctoral scholars at Stanford to build an inclusive, diverse, and equitable professoriate. Dr. Abudayyeh’s discoveries have resulted in more than 15 patents or pending patent applications, which have been licensed to multiple biotechnology companies. He received a B.S. Our team and founders include Engineering Biology pioneers with world-leading expertise in CRISPR and Synthetic Biology, diagnostic industry veterans, and disease-area authorities. Dr. Golub is the Charles A. Dana Investigator at the Dana-Farber Cancer Institute, a professor of pediatrics at Harvard Medical School, and a Howard Hughes Medical Institute Investigator. He also serves on the Board of Directors of the Damon Runyon Cancer Research Foundation and is a trustee of the Boston Symphony Orchestra. Omar Abudayyeh, Ph.D., is a McGovern Institute Fellow at the Massachusetts Institute of Technology, and previously conducted research as a graduate student at Harvard Medical School and the Harvard-MIT Health Sciences and Technology program. We have an active diversity recruitment program, and strongly encourage applications from traditionally underrepresented minorities, those from disadvantaged backgrounds, and those with disabilities. in Physiology and his M.D. Ultimately, many philosophers became convinced that Carnap’s conventionalist program was fundamentally flawed. I agree to allow Sherlock Biosciences to store and process my personal data. He has made fundamental discoveries in the molecular basis of childhood leukemia and laid the foundation for the diagnosis and classification of human cancers using genomics. He has received numerous awards and honors, including a Rhodes Scholarship, a MacArthur “Genius” Award, an NIH Director’s Pioneer Award, the Sanofi-Institut Pasteur Award, as well as several teaching awards. His work has generated more than 15 patents or pending patent applications, which have been licensed to multiple biotechnology companies. Dr. Collins received a B.A. Sherlock Biosciences is developing the most advanced platforms in molecular testing to offer unparalleled breadth and versatility for diagnostic solutions. We combine the diagnostic power of SHERLOCK with that of a second core platform technology, Internal Splint-Pairing Expression Cassette Translation Reaction, or INSPECTRTM, to create diagnostic tools that are simple and easy to use in virtually any setting, and at the same time provide accurate, rapid and affordable results. Stanford School of Engineering Dr. Gootenberg is a recipient of the Department of Energy Computational Science Graduate Fellowship, the National Science Foundation Graduate Research Fellowship, and the National Defense Science and Engineering Fellowship. Scholarship Country: United States of America University: Stanford University No.of Scholarships: 17,00 Undergraduates, 100 Graduates; Course Level: Bachelors, Masters, Ph.D., MS, MBA, MFA, MD, JD Degrees. Dr. Hung is a physician-scientist at the Broad Institute of MIT and Harvard, the Department of Molecular Biology at the Massachusetts General Hospital, and the Department of Genetics at Harvard Medical School, and is the Co-Director of the Infectious Disease and Microbiome Program at the Broad Institute. Dr. Zhang’s contributions to science have been recognized by numerous awards including the Canada Gairdner International Award, the Tang Prize, the Keio Medical Prize, the Lemelson-MIT Prize, and the Albany Medical Center Prize. For non-technical support inquiries, please complete this form to contact us with a general question or with an inquiry about sales, product availability, collaborations, or partnership opportunities. See our Diversity page for more information. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website.